IPP Bureau
Apollo Telehealth revolutionizes healthcare access through innovation
By IPP Bureau - September 20, 2023
Apollo Telehealth has established more than 700 centers, in 7 states
Henkel joins MedTech Europe to drive innovation in the medical technology industry
By IPP Bureau - September 20, 2023
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
INEOS Styrolution Introduces New ASA Grade for small medical devices
By IPP Bureau - September 20, 2023
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
Biovyn PVC to be used in sustainable prosthetics for the first time
By IPP Bureau - September 20, 2023
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Cenexi appoints Jim McPherson as CEO
By IPP Bureau - September 20, 2023
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Briefs: Caplin Steriles, Zydus and APL Healthcare
By IPP Bureau - September 20, 2023
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Fortis Bannerghatta conducts Karnataka's first pediatric robot-assisted surgery
By IPP Bureau - September 20, 2023
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Biocon names Peter Bains as Group CEO
By IPP Bureau - September 19, 2023
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Galgotias University, HCL Healthcare to bring medical center to Greater Noida Campus
By IPP Bureau - September 19, 2023
The partnership acknowledges the increasing mental health challenges faced by students in today's society
Remedi introduces best handheld X-ray solution to India
By IPP Bureau - September 19, 2023
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
By IPP Bureau - September 19, 2023
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
By IPP Bureau - September 19, 2023
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Takeda reiterates the need of equitable access to healthcare for universal impact
By IPP Bureau - September 18, 2023
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
CAHO and PFPSF launch Patient Advisory Councils
By IPP Bureau - September 18, 2023
Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery
RML Hospital inaugurates India’s first dedicated OPD for transgenders
By IPP Bureau - September 18, 2023
Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community
